US2012252053A1PendingUtilityA1

Reagents and methods and systems using them

39
Assignee: SCOTT W JAMESPriority: Sep 30, 2010Filed: Jun 11, 2012Published: Oct 4, 2012
Est. expirySep 30, 2030(~4.2 yrs left)· nominal 20-yr term from priority
Inventors:W. James Scott
Y10T436/23Y10T436/107497G01N 33/84Y10S435/81Y10T436/108331
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Certain embodiments described herein are directed to a reagent that includes an effective amount of an adsorber to remove interfering species present during heavy metal level measurement in a fluid sample. In some examples, the reagent can include an effective amount of an adsorber to remove a suitable amount of glutathione from the fluid sample such that the glutathione does not interfere with measurements of lead levels in the fluid sample.

Claims

exact text as granted — not AI-modified
1 - 40 . (canceled) 
     
     
         41 . A method of measuring a level of a heavy metal in a mammalian fluid sample, the method comprising:
 adding the mammalian fluid sample to a container comprising an effective amount of a lysing agent to lyse cells in the mammalian fluid sample and an effective amount of an adsorber to adsorb sulfhydryl species present in the lysed fluid sample; and   detecting the level of the heavy metal present in the lysed fluid sample.   
     
     
         42 . The method of  claim 41 , further comprising configuring the lysing agent to lyse the cells and not remove substantial amounts of heavy metal from the mammalian fluid sample. 
     
     
         43 . The method of  claim 41 , further comprising configuring the lysing agent to be an acid. 
     
     
         44 . The method of  claim 41 , further comprising detecting lead in the lysed fluid sample using a gold colloid sensor. 
     
     
         45 . The method of  claim 41 , further comprising configuring the adsorber to be effective to adsorb glutathione in the mammalian fluid sample. 
     
     
         46 . The method of  claim 41 , further comprising configuring the adsorber as a powder that comprises an average particle size of less than or equal to 100 microns. 
     
     
         47 . The method of  claim 41 , further comprising configuring the adsorber as a powder that comprises a surface area of at least 1000 m 2 /g. 
     
     
         48 . The method of  claim 41 , further comprising configuring the adsorber as a powdered activated carbon. 
     
     
         49 . The method of  claim 48 , further comprising configuring the adsorber with a non-activated carbon. 
     
     
         50 . The method of  claim 41 , further comprising configuring the mammalian fluid sample as fresh blood. 
     
     
         51 . A method of facilitating measurement of a heavy metal in a mammalian fluid sample, the method comprising providing an effective amount of an adsorber to be added to a treatment reagent selected to lyse cells in the mammalian fluid sample. 
     
     
         52 . The method of  claim 51 , further comprising providing a sensor configured to bind to the heavy metal in the lysed, mammalian fluid sample. 
     
     
         53 . The method of  claim 52 , further comprising providing a device configured to read the sensor with bound heavy metal. 
     
     
         54 . The method of  claim 51 , further comprising providing a container comprising heparin and configured to receive the mammalian fluid sample. 
     
     
         55 . The method of  claim 51 , further comprising configuring the treatment reagent as an effective amount of an acid to lyse the cells. 
     
     
         56 . A method of facilitating measurement of lead in a mammalian blood sample, the method comprising providing an effective amount of an adsorber to be added to a treatment reagent selected to lyse cells in the mammalian blood sample. 
     
     
         57 . The method of  claim 56 , further comprising providing a sensor configured to bind to the lead in the lysed, mammalian blood sample. 
     
     
         58 . The method of  claim 57 , further comprising providing a device configured to read the sensor with bound lead. 
     
     
         59 . The method of  claim 56 , further comprising providing a container comprising heparin and configured to receive the mammalian blood sample. 
     
     
         60 . The method of  claim 56 , further comprising configuring the treatment reagent as an effective amount of hydrochloric acid to lyse the cells.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.